Bluebird Bio Stock Return On Asset
| BLUE Stock | USD 0.92 0.01 1.10% |
Bluebird bio fundamentals help investors to digest information that contributes to Bluebird Bio's financial success or failures. It also enables traders to predict the movement of Bluebird Stock. The fundamental analysis module provides a way to measure Bluebird Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bluebird Bio stock.
As of April 29, 2024, Return On Assets is expected to decline to -0.58. Bluebird | Return On Asset |
Bluebird bio Company Return On Asset Analysis
Bluebird Bio's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Bluebird Bio Return On Asset | -0.15 |
Most of Bluebird Bio's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bluebird bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bluebird Return On Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Bluebird Bio is extremely important. It helps to project a fair market value of Bluebird Stock properly, considering its historical fundamentals such as Return On Asset. Since Bluebird Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bluebird Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bluebird Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Bluebird Total Assets
Total Assets |
|
Based on the latest financial disclosure, Bluebird bio has a Return On Asset of -0.1501. This is 98.28% lower than that of the Biotechnology sector and 99.36% lower than that of the Health Care industry. The return on asset for all United States stocks is 7.21% higher than that of the company.
Bluebird Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bluebird Bio's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bluebird Bio could also be used in its relative valuation, which is a method of valuing Bluebird Bio by comparing valuation metrics of similar companies.Bluebird Bio is currently under evaluation in return on asset category among related companies.
Bluebird Fundamentals
| Return On Equity | -0.48 | ||||
| Return On Asset | -0.15 | ||||
| Operating Margin | (6.84) % | ||||
| Current Valuation | 230.31 M | ||||
| Shares Outstanding | 192.74 M | ||||
| Shares Owned By Insiders | 0.37 % | ||||
| Shares Owned By Institutions | 65.14 % | ||||
| Number Of Shares Shorted | 32.62 M | ||||
| Price To Earning | (19.32) X | ||||
| Price To Book | 0.96 X | ||||
| Price To Sales | 9.76 X | ||||
| Revenue | 21.73 M | ||||
| Gross Profit | (247.24 M) | ||||
| EBITDA | (131.77 M) | ||||
| Net Income | (91.17 M) | ||||
| Cash And Equivalents | 132.51 M | ||||
| Cash Per Share | 1.72 X | ||||
| Total Debt | 281.39 M | ||||
| Debt To Equity | 1.63 % | ||||
| Current Ratio | 1.12 X | ||||
| Book Value Per Share | 2.08 X | ||||
| Cash Flow From Operations | (277.48 M) | ||||
| Short Ratio | 4.81 X | ||||
| Earnings Per Share | (0.63) X | ||||
| Price To Earnings To Growth | 0.32 X | ||||
| Target Price | 4.16 | ||||
| Number Of Employees | 323 | ||||
| Beta | 0.8 | ||||
| Market Capitalization | 177.86 M | ||||
| Total Asset | 554.9 M | ||||
| Retained Earnings | (3.99 B) | ||||
| Working Capital | 71.25 M | ||||
| Current Asset | 523.97 M | ||||
| Current Liabilities | 40.37 M | ||||
| Net Asset | 554.9 M |
About Bluebird Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bluebird bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bluebird Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bluebird bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Bluebird Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bluebird Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Bluebird Stock
| 0.61 | DRRX | Durect Earnings Call This Week | PairCorr |
Moving against Bluebird Stock
| 0.49 | ACB | Aurora Cannabis Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Bluebird Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bluebird Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bluebird Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bluebird bio to buy it.
The correlation of Bluebird Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bluebird Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bluebird bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bluebird Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Bluebird Bio Piotroski F Score and Bluebird Bio Altman Z Score analysis. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Bluebird Stock analysis
When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Bluebird Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Revenue Per Share 0.214 | Quarterly Revenue Growth 173.535 | Return On Assets (0.15) | Return On Equity (0.48) |
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.